volume 9, issue 9, P5645-5654 2020
DOI: 10.21037/tcr-20-608
View full text

Abstract: the new cases of CRC reported in 2018 occurred in Asia (1). At diagnosis, 25% of patients have metastatic disease and nearly half of all patients without metastases will develop metastatic CRC (mCRC) (3).In 2016, CRC accounted for 14.5% of all malignant tumors and for 12.0% of all cancer-related deaths in Taiwan. CRC was the most common cancer in men and the second most common cancer in women (4). Over 15,000 patients are diagnosed with CRC annually, with CRC accounting for 41.9% of all malignancies of the dig…

expand abstract